What is NovoCure's R&D?

NovoCure (NVCR) reported R&D of $58.34M in Q1 2026.

How has NovoCure's R&D changed year-over-year?

NovoCure's R&D increased by 8.5% year-over-year, from $53.78M to $58.34M.

What is the long-term trend for NovoCure's R&D?

Over 4 years (2021 to 2025), NovoCure's R&D has grown at a 2.8% compound annual growth rate (CAGR), from $201.3M to $224.54M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

NovoCure NVCR R&D

R&D at other companies

MedtronicMDT

$671M-1.9%

Iovance Biotherapeutics, Inc.IOVA

$62.49M-17.7%

Nuvation BioNUVB

$35.05M+42.5%

Vir Biotechnology, Inc.VIR

$108.92M-8.2%

Syndax PharmaceuticalsSNDX

$58.85M-4.5%

ArriVent BioPharma, Inc.AVBP

$37.62M-38.6%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's R&D?: NovoCure (NVCR) reported R&D of $58.34M in Q1 2026.
How has NovoCure's R&D changed year-over-year?: NovoCure's R&D increased by 8.5% year-over-year, from $53.78M to $58.34M.
What is the long-term trend for NovoCure's R&D?: Over 4 years (2021 to 2025), NovoCure's R&D has grown at a 2.8% compound annual growth rate (CAGR), from $201.3M to $224.54M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.